Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,977 | 185 | 80.4% |
| Travel and Lodging | $815.78 | 3 | 16.5% |
| Education | $135.29 | 7 | 2.7% |
| Gift | $16.65 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $1,442 | 14 | $0 (2020) |
| Astellas Pharma US Inc | $991.29 | 52 | $0 (2023) |
| ABBVIE INC. | $199.40 | 11 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $199.24 | 12 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $189.00 | 13 | $0 (2023) |
| Boston Scientific Corporation | $144.89 | 5 | $0 (2020) |
| Retrophin, Inc. | $135.20 | 4 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $126.30 | 6 | $0 (2023) |
| PFIZER INC. | $119.28 | 8 | $0 (2020) |
| Rochester Medical Corporation | $109.76 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187.60 | 8 | ACCORD HEALTHCARE, INC. ($49.43) |
| 2023 | $434.65 | 19 | Astellas Pharma US Inc ($126.86) |
| 2022 | $293.95 | 13 | AngioDynamics, Inc. ($85.32) |
| 2021 | $64.30 | 4 | Myovant Sciences Inc. ($23.93) |
| 2020 | $327.91 | 12 | NeoTract Inc. ($127.00) |
| 2019 | $2,139 | 54 | NeoTract Inc. ($1,269) |
| 2018 | $884.99 | 51 | Astellas Pharma US Inc ($212.41) |
| 2017 | $612.52 | 35 | Astellas Pharma US Inc ($230.55) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $20.01 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Urology | ||||||
| 10/25/2024 | ACCORD HEALTHCARE, INC. | — | Gift | Cash or cash equivalent | $16.65 | General |
| 09/17/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 04/22/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $29.10 | General |
| Category: ONCOLOGY | ||||||
| 03/12/2024 | Ethicon US, LLC | Echelon; Endopath (Device) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Endo-Mechanical | ||||||
| 02/01/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Surgical Care | ||||||
| 01/30/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: Oncology | ||||||
| 12/20/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/20/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/10/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: Urology | ||||||
| 09/13/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: UROLOGY | ||||||
| 09/06/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Oncology | ||||||
| 08/16/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Urology | ||||||
| 07/14/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Urology | ||||||
| 06/12/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Prostate Cancer | ||||||
| 06/08/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Urology | ||||||
| 04/26/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Genetic Disease | ||||||
| 03/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 03/16/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: ONCOLOGY | ||||||
| 03/07/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Urology | ||||||
| 02/22/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Urology | ||||||
| 02/17/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Urology | ||||||
| 02/13/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 913 | 1,102 | $333,403 | $67,483 |
| 2022 | 15 | 878 | 1,094 | $304,735 | $68,828 |
| 2021 | 14 | 902 | 1,144 | $324,520 | $75,442 |
| 2020 | 16 | 916 | 1,168 | $240,429 | $59,295 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 243 | $74,844 | $14,988 | 20.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 53 | 62 | $51,398 | $11,752 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 101 | $44,036 | $9,706 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $31,808 | $6,217 | 19.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 17 | 18 | $26,326 | $5,858 | 22.3% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 15 | 15 | $16,470 | $3,830 | 23.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 28 | 29 | $20,271 | $3,268 | 16.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 16 | $13,264 | $2,913 | 22.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $8,809 | $2,091 | 23.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $7,524 | $1,660 | 22.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 158 | 184 | $8,464 | $1,413 | 16.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $5,316 | $1,242 | 23.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 12 | $18,975 | $1,217 | 6.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 12 | 14 | $2,968 | $667.29 | 22.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 203 | 275 | $2,750 | $605.00 | 22.0% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 15 | 30 | $180.00 | $56.44 | 31.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 60 | 72 | $55,296 | $13,280 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 176 | 214 | $59,706 | $12,902 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 132 | $52,008 | $12,890 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $36,050 | $8,695 | 24.1% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 14 | 14 | $18,708 | $4,803 | 25.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 14 | 15 | $15,120 | $3,877 | 25.6% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 15 | 15 | $11,370 | $2,934 | 25.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 23 | 23 | $14,766 | $2,745 | 18.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $7,826 | $2,058 | 26.3% |
About Dr. Daniel Miller, MD
Dr. Daniel Miller, MD is a Urology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1508032525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Miller, MD has received a total of $4,945 in payments from pharmaceutical and medical device companies, with $187.60 received in 2024. These payments were reported across 196 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($3,977).
As a Medicare-enrolled provider, Miller has provided services to 3,609 Medicare beneficiaries, totaling 4,508 services with total Medicare billing of $271,049. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Portland, OR
- Active Since 04/30/2008
- Last Updated 12/05/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1508032525
Products in Payments
- UroLift (Device) $1,442
- XTANDI (Drug) $412.43
- Myrbetriq (Drug) $276.78
- MYRBETRIQ (Drug) $253.69
- PROVENGE (Drug) $199.24
- XIAFLEX (Biological) $164.98
- (815) Thiola (Drug) $135.20
- BOTOX (Biological) $126.88
- Xtandi (Drug) $97.49
- NANOKNIFE (Device) $85.32
- GEMTESA (Drug) $74.89
- Xofigo (Drug) $69.79
- ELIGARD (Drug) $67.30
- Nubeqa (Drug) $56.51
- PYLARIFY (Drug) $56.21
- BOTOX THERAPEUTIC (Biological) $54.83
- Lupron (Drug) $48.82
- OXLUMO (Drug) $48.14
- NOCDURNA (Drug) $46.63
- Lupron Depot (Drug) $44.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Portland
Dr. Lance Marr, M.d, M.D
Urology — Payments: $277,964
Dr. Geolani Dy, M.d, M.D
Urology — Payments: $69,493
Jyoti Chouhan, Do, Pharmd, DO, PHARMD
Urology — Payments: $62,636
David Sobel, Md, MD
Urology — Payments: $41,221
Dr. James Tycast, M.d, M.D
Urology — Payments: $38,374
Amir Patel
Urology — Payments: $35,329